Hans Martin Mueller | Director, BioProcess Development

Hans Martin Mueller, Director, BioProcess Development, MSD

Martin Mueller, Ph.D., Biotech Engineer, started his career at a Biotech startup in Berlin, before being a GLP study director at the globally acting CRO “RCC” (today: Harlan Labs). With this experience he joined Schering-Plough’s Biotech division for building up the Global GMP Labs. In 2012, Martin accepted a leading position within MSD’s BioProcess Division in New Jersey, U.S.. Today he manages a local MSD-team in Switzerland and international teams for developing MSD’s top biologics pipeline. 


European Antibody Congress 2018, Day 1 @ 17:30

Modern analytical development of biologics

  • Feasibility of modern analytical tools for biologics development
  • Innovative approaches for process analytics
  • Trends and upcoming requirements for the analytical control of biopharmaceuticals
last published: 29/Oct/18 16:25 GMT
last published: 29/Oct/18 16:25 GMT

back to speakers

There are two parts to the Festival of Biologics: the five world-class international conferences covering Antibodies, Immunotherapy, BioSimilars, Clinical Trials, and High Potency APIs; and an exhibition featuring the most exciting technology and solutions for pharma and biotech. There is a registration fee to attend the conferences. To visit the exhibition is free.


Conference 29 - 31 October • Exhibition & Seminars 29 - 31 October

Sign Up for Event Updates